chr16-18793089-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_015161.3(ARL6IP1):c.*163A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0966 in 547,234 control chromosomes in the GnomAD database, including 2,889 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.097 ( 767 hom., cov: 33)
Exomes 𝑓: 0.096 ( 2122 hom. )
Consequence
ARL6IP1
NM_015161.3 3_prime_UTR
NM_015161.3 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.22
Genes affected
ARL6IP1 (HGNC:697): (ADP ribosylation factor like GTPase 6 interacting protein 1) This gene belongs to the ARL6ip family and encodes a transmembrane protein that is predominantly localized to intracytoplasmic membranes. It is highly expressed in early myeloid progenitor cells and thought to be involved in protein transport, membrane trafficking, or cell signaling during hematopoietic maturation. Mutations in this gene are associated with spastic paraplegia 61 (SPG61). Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Sep 2015]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 16-18793089-T-C is Benign according to our data. Variant chr16-18793089-T-C is described in ClinVar as [Benign]. Clinvar id is 1231012.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.144 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARL6IP1 | NM_015161.3 | c.*163A>G | 3_prime_UTR_variant | Exon 6 of 6 | ENST00000304414.12 | NP_055976.1 | ||
ARL6IP1 | NM_001313858.1 | c.*163A>G | 3_prime_UTR_variant | Exon 6 of 6 | NP_001300787.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0975 AC: 14836AN: 152166Hom.: 769 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
14836
AN:
152166
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0962 AC: 37999AN: 394950Hom.: 2122 Cov.: 4 AF XY: 0.0984 AC XY: 20756AN XY: 210962 show subpopulations
GnomAD4 exome
AF:
AC:
37999
AN:
394950
Hom.:
Cov.:
4
AF XY:
AC XY:
20756
AN XY:
210962
show subpopulations
African (AFR)
AF:
AC:
856
AN:
9848
American (AMR)
AF:
AC:
2371
AN:
17056
Ashkenazi Jewish (ASJ)
AF:
AC:
2062
AN:
11880
East Asian (EAS)
AF:
AC:
2167
AN:
27428
South Asian (SAS)
AF:
AC:
4522
AN:
33624
European-Finnish (FIN)
AF:
AC:
2163
AN:
30268
Middle Eastern (MID)
AF:
AC:
261
AN:
1674
European-Non Finnish (NFE)
AF:
AC:
21158
AN:
240594
Other (OTH)
AF:
AC:
2439
AN:
22578
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1593
3187
4780
6374
7967
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.0975 AC: 14846AN: 152284Hom.: 767 Cov.: 33 AF XY: 0.100 AC XY: 7475AN XY: 74466 show subpopulations
GnomAD4 genome
AF:
AC:
14846
AN:
152284
Hom.:
Cov.:
33
AF XY:
AC XY:
7475
AN XY:
74466
show subpopulations
African (AFR)
AF:
AC:
3504
AN:
41558
American (AMR)
AF:
AC:
2274
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
AC:
624
AN:
3470
East Asian (EAS)
AF:
AC:
638
AN:
5192
South Asian (SAS)
AF:
AC:
615
AN:
4826
European-Finnish (FIN)
AF:
AC:
828
AN:
10604
Middle Eastern (MID)
AF:
AC:
51
AN:
294
European-Non Finnish (NFE)
AF:
AC:
6020
AN:
68024
Other (OTH)
AF:
AC:
262
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
705
1410
2114
2819
3524
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
438
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Apr 19, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.